There are also tyrosine kinase inhibitors (TKI) approved for cancer: Sorafenib, Sunitinib, Regorafenib, etc. There are many reviews on the anti-VEGF-based therapies, so we decided to not go into much detail. Here, VEGFA is linked to cancer.